两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-011470 Size: 5 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-011468 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 内部交易: 2020-11-24,Director,MARINO JAMES J ,买入,38774普通股, $0.26
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-011442 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-20-128212 Act: 34 Size: 36 KB 网页链接
$Onconova医疗(ONTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-20-125819 Act: 34 Size: 5 MB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-124414 Act: 34 Size: 79 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, item 3.01 Accession Number: 0001104659-20-113957 Act: 34 Size: 19 KB 网页链接
$Onconova医疗(ONTX)$ 内部交易: 2020-08-27,Director,Hoffman Michael B ,卖出,182492普通股, $0.27
$Onconova医疗(ONTX)$ 内部交易: 2020-08-27,Director,Hoffman Michael B ,卖出,1876普通股, $0.27